NewsBenzingaFractyl Health Announces Heightened Focus On Advancing Revita Toward Potential FDA Marketing Authorization And Commercialization In Post-GLP-1 Weight Maintenance Fractyl Health Announces Heightened Focus On Advancing Revita Toward Potential FDA Marketing Authorization And Commercialization In Post-GLP-1 Weight Maintenance Benzinga 2026.10.22 11:07 (GMT+0) Open on Benzinga Other news Citigroup Maintains Buy on Fifth Third Bancorp, Raises Price Target to $63 Citigroup Maintains Buy on East West Bancorp, Raises Price Target to $155 Citigroup Maintains Neutral on BOK Financial, Lowers Price Target to $140 Citigroup Maintains Buy on Westinghouse Air Brake, Lowers Price Target to $334 Citigroup Maintains Neutral on Integra Lifesciences, Lowers Price Target to $14 Citigroup Maintains Buy on Pegasystems, Lowers Price Target to $50
